Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFutura Medical Regulatory News (FUM)

Share Price Information for Futura Medical (FUM)

Share Price is delayed by 15 minutes
Get Live Data
0.546    -0.034 (-5.86%)
Bid:
0.55
Ask:
0.60
Spread: 0.05 (9.091%)
Market Cap: £3.17m
FUM Live PriceLast checked at - London Stock Exchange

Intraday Futura Medical Share Chart

Blocklisting Interim Review

23 Nov 2015 15:42

RNS Number : 6661G
Futura Medical PLC
23 November 2015
Ā 

23 November 2015

Ā 

Ā 

Ā 

Futura Medical plc

("Futura" or "the Company")

Ā 

Block Listing Update

Ā 

Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology announces that, since the last update in May 2015, there have been no changes to the numbers of shares block listed in respect of the Company's two option plans. All ordinary shares of 0.2 pence each.

The table below provides further detail.

Ā 

Name of company:

Futura Medical plc

Name of scheme:

Unapproved Share Option Scheme ("USOS")EMI Share Option Scheme ("EMI")

Ā 

Period of return:

From:

12 May 2015

To:

23 November 2015

Ā 

Number and class of securities not issued under the scheme(s)

USOS:

1,440,600

EMI:

1,394,141

Total:

2,834,741

Ā 

Ā 

Number of securities issued under the scheme(s) during the period

Ā 

Ā 

Number of securities lapsed under the scheme(s) during the period

USOS:

Nil

EMI:

Ā 

Ā 

USOS:

EMI:

Ā 

Ā 

Nil

Ā 

Ā 

Nil

Nil

Ā 

Ā 

Balance under the scheme(s) of securities not yet issued at the end of the period

USOS:

1,440,600

EMI:

1,394,141

Total:

2,834,741

Ā 

Number and class of securities originally admitted and the date of admission

USOS:

814,424 on 25 May 2011 and 1,202,280 on 8 October 2013

USOS Total:

Ā 

2,016,704

EMI:

1,520,576 on 25 May 2011 and 1,467,720 on 8 October 2013

EMI Total:

2,988,296

Total:

5,005,000

Ā 

Ā 

Name of contact:

Derek Martin, Chief Financial Officer

Telephone number of contact:

+44 (0) 1483 685 670

Ā 

Ā 

For further information please contact:

Ā 

Futura Medical plc

Ā 

James Barder, Chief Executive

Tel: +44 (0) 1483 685 670

Email to: james.barder@futuramedical.com

www.futuramedical.com

Ā 

N+1 Singer (Nominated Adviser and Broker)

Ā 

Aubrey Powell / Liz Yong / Tom SmaleCorporate Finance

Ā 

Tel:+44 (0) 20 7496 3000

For media enquiries please contact:

Ā 

Buchanan

Ā 

Mark Court / Sophie Cowles / Stephanie Watson

Tel: +44 (0) 20 7466 5000

Ā 

Ā 

Notes to Editors

Ā 

Futura Medical plc

Ā 

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Ā 

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

This information is provided by RNS
The company news service from the London Stock Exchange
Ā 
END
Ā 
Ā 
BLREXLFLEFFXFBX
Date   Source Headline
6th May 20224:41 pmRNSSecond Price Monitoring Extn
6th May 20224:35 pmRNSPrice Monitoring Extension
26th Apr 20227:00 amRNSFull Year Results 2021
14th Apr 20223:54 pmRNSFutura Medical Notice of Preliminary Results 2021
11th Apr 20224:28 pmRNSTR-1: Notification of major holdings
1st Apr 20224:58 pmRNSTR-1: Notification of major holdings
23rd Mar 20227:00 amRNSFutura Announces Collaboration with Menarini
2nd Feb 20225:30 pmRNSTR-1:Notification of major holdings
13th Jan 202210:32 amRNSRemuneration of Non-Executive Directors and TVR
20th Dec 20217:00 amRNSUS regulatory and commercial update for MED3000
2nd Dec 202112:02 pmRNSTR-1: Notification of major holdings
30th Nov 20217:00 amRNSBlock Listing Six Monthly Return
30th Nov 20217:00 amRNSFutura Medical plc Total Voting Rights
28th Oct 20217:00 amRNSFutura Medical plc Board Appointment
8th Oct 20217:00 amRNSFutura Medical plc Board Appointment
5th Oct 20214:05 pmRNSDirector/PDMR Shareholding
29th Sep 20217:00 amRNSInterim Results for Six Months ended 30 June 2021
27th Sep 20217:00 amRNSFutura Announces Collaboration with Labatec Pharma
17th Sep 20217:00 amRNSNotice of Interim Results
15th Sep 20217:00 amRNSFirst Patient visit in MED3000 Confirmatory Study
8th Sep 20213:49 pmRNSTR1: Notification of Major Holdings
31st Aug 20217:00 amRNSFutura Medical Announces Collaboration of MED3000
19th Jul 20217:00 amRNSFDA regulatory and commercial update for MED3000
28th Jun 20211:26 pmRNSResult of AGM
28th Jun 20217:00 amRNSAGM Statement
25th Jun 20212:55 pmRNSTR1: Notification of Major Holdings
15th Jun 20213:48 pmRNSTR-1: Notification of major holdings
9th Jun 20213:58 pmRNSTR-1: Notification of major holdings
3rd Jun 20214:19 pmRNSTR-1: Notification of major holdings
3rd Jun 202111:00 amRNSNotice of AGM and Annual Report
2nd Jun 202112:50 pmRNSResult of General Meeting & Total Voting Rights
1st Jun 20217:00 amRNSBlock Listing Six Monthly Return
17th May 20213:08 pmRNSPosting of Circular and Notice of General Meeting
17th May 20217:00 amRNSResult of Placing and Retail Offer
14th May 20214:41 pmRNSSecond Price Monitoring Extn
14th May 20214:35 pmRNSPrice Monitoring Extension
14th May 20214:31 pmRNSRetail Offer by PrimaryBid
14th May 20214:30 pmRNSProposed Placing to raise £10 mil & Retail Offer
4th May 20215:18 pmRNSTR-1: Notification of major holdings
4th May 20215:15 pmRNSTR-1: Notification of major holdings
4th May 20217:00 amRNSTotal Voting Rights
30th Apr 20217:00 amRNSFutura Receives Approval from EU Notified Body
28th Apr 20212:57 pmRNSTR-1: Notification of major holdings
28th Apr 20219:31 amRNSTR-1: Notification of major holdings
22nd Apr 20214:58 pmRNSTR-1: Notification of major holdings
19th Apr 20214:03 pmRNSCorrection – Conversion of Convertible Loan Notes
15th Apr 20212:42 pmRNSConversion of Convertible Loan Notes
14th Apr 20213:40 pmRNSRemuneration of Non-Executive Directors and TVR
14th Apr 20217:00 amRNSFull Year Results for the year ended 31 Dec 2020
1st Apr 20214:20 pmRNSExercise of Warrants, Issue of Equity & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.